Cargando…
Breath of Life: Heart Disease Link to Developmental Hypoxia
Heart disease remains one of the greatest killers. In addition to genetics and traditional lifestyle risk factors, we now understand that adverse conditions during pregnancy can also increase susceptibility to cardiovascular disease in the offspring. Therefore, the mechanisms by which this occurs an...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542082/ https://www.ncbi.nlm.nih.gov/pubmed/34694887 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.054689 |
_version_ | 1784589365293350912 |
---|---|
author | Giussani, Dino A. |
author_facet | Giussani, Dino A. |
author_sort | Giussani, Dino A. |
collection | PubMed |
description | Heart disease remains one of the greatest killers. In addition to genetics and traditional lifestyle risk factors, we now understand that adverse conditions during pregnancy can also increase susceptibility to cardiovascular disease in the offspring. Therefore, the mechanisms by which this occurs and possible preventative therapies are of significant contemporary interest to the cardiovascular community. A common suboptimal pregnancy condition is a sustained reduction in fetal oxygenation. Chronic fetal hypoxia results from any pregnancy with increased placental vascular resistance, such as in preeclampsia, placental infection, or maternal obesity. Chronic fetal hypoxia may also arise during pregnancy at high altitude or because of maternal respiratory disease. This article reviews the short- and long-term effects of hypoxia on the fetal cardiovascular system, and the importance of chronic fetal hypoxia in triggering a developmental origin of future heart disease in the adult progeny. The work summarizes evidence derived from human studies as well as from rodent, avian, and ovine models. There is a focus on the discovery of the molecular link between prenatal hypoxia, oxidative stress, and increased cardiovascular risk in adult offspring. Discussion of mitochondria-targeted antioxidant therapy offers potential targets for clinical intervention in human pregnancy complicated by chronic fetal hypoxia. |
format | Online Article Text |
id | pubmed-8542082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-85420822021-10-27 Breath of Life: Heart Disease Link to Developmental Hypoxia Giussani, Dino A. Circulation State of the Art Heart disease remains one of the greatest killers. In addition to genetics and traditional lifestyle risk factors, we now understand that adverse conditions during pregnancy can also increase susceptibility to cardiovascular disease in the offspring. Therefore, the mechanisms by which this occurs and possible preventative therapies are of significant contemporary interest to the cardiovascular community. A common suboptimal pregnancy condition is a sustained reduction in fetal oxygenation. Chronic fetal hypoxia results from any pregnancy with increased placental vascular resistance, such as in preeclampsia, placental infection, or maternal obesity. Chronic fetal hypoxia may also arise during pregnancy at high altitude or because of maternal respiratory disease. This article reviews the short- and long-term effects of hypoxia on the fetal cardiovascular system, and the importance of chronic fetal hypoxia in triggering a developmental origin of future heart disease in the adult progeny. The work summarizes evidence derived from human studies as well as from rodent, avian, and ovine models. There is a focus on the discovery of the molecular link between prenatal hypoxia, oxidative stress, and increased cardiovascular risk in adult offspring. Discussion of mitochondria-targeted antioxidant therapy offers potential targets for clinical intervention in human pregnancy complicated by chronic fetal hypoxia. Lippincott Williams & Wilkins 2021-10-26 2021-10-26 /pmc/articles/PMC8542082/ /pubmed/34694887 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.054689 Text en © 2021 The Authors. https://creativecommons.org/licenses/by/4.0/Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
spellingShingle | State of the Art Giussani, Dino A. Breath of Life: Heart Disease Link to Developmental Hypoxia |
title | Breath of Life: Heart Disease Link to Developmental Hypoxia |
title_full | Breath of Life: Heart Disease Link to Developmental Hypoxia |
title_fullStr | Breath of Life: Heart Disease Link to Developmental Hypoxia |
title_full_unstemmed | Breath of Life: Heart Disease Link to Developmental Hypoxia |
title_short | Breath of Life: Heart Disease Link to Developmental Hypoxia |
title_sort | breath of life: heart disease link to developmental hypoxia |
topic | State of the Art |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542082/ https://www.ncbi.nlm.nih.gov/pubmed/34694887 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.054689 |
work_keys_str_mv | AT giussanidinoa breathoflifeheartdiseaselinktodevelopmentalhypoxia |